Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Antibodies to surface dopamine-2 receptor and N-methyl-D-aspartate receptor in the first episode of acute psychosis in children.

Pathmanandavel K, Starling J, Merheb V, Ramanathan S, Sinmaz N, Dale RC, Brilot F.

Biol Psychiatry. 2015 Mar 15;77(6):537-47. doi: 10.1016/j.biopsych.2014.07.014. Epub 2014 Jul 23.

PMID:
25168608
2.

Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.

Dale RC, Merheb V, Pillai S, Wang D, Cantrill L, Murphy TK, Ben-Pazi H, Varadkar S, Aumann TD, Horne MK, Church AJ, Fath T, Brilot F.

Brain. 2012 Nov;135(Pt 11):3453-68. doi: 10.1093/brain/aws256. Epub 2012 Oct 11.

PMID:
23065479
3.

N-Methyl-D-Aspartate Receptor Autoantibodies in Psychiatric Illness.

Zandi MS, Lennox B, Vincent A.

Biol Psychiatry. 2016 May 1;79(9):e61. doi: 10.1016/j.biopsych.2015.03.034. Epub 2015 Jun 9. No abstract available.

PMID:
26185011
4.

Reply to: N-Methyl-D-Aspartate Receptor Autoantibodies in Psychiatric Illness.

Kayser MS, Dalmau J.

Biol Psychiatry. 2016 May 1;79(9):e63. doi: 10.1016/j.biopsych.2015.05.023. Epub 2015 Jun 9. No abstract available.

PMID:
26187407
5.

Fact or fiction? Examining a role for N-methyl-D-aspartate receptor autoantibodies in psychiatric illness.

Kayser MS.

Biol Psychiatry. 2015 Mar 15;77(6):506-7. doi: 10.1016/j.biopsych.2014.12.005. No abstract available.

6.

Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.

Hara M, Martinez-Hernandez E, Ariño H, Armangué T, Spatola M, Petit-Pedrol M, Saiz A, Rosenfeld MR, Graus F, Dalmau J.

Neurology. 2018 Apr 17;90(16):e1386-e1394. doi: 10.1212/WNL.0000000000005329. Epub 2018 Mar 16.

7.

Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.

Steiner J, Walter M, Glanz W, Sarnyai Z, Bernstein HG, Vielhaber S, Kästner A, Skalej M, Jordan W, Schiltz K, Klingbeil C, Wandinger KP, Bogerts B, Stoecker W.

JAMA Psychiatry. 2013 Mar;70(3):271-8. doi: 10.1001/2013.jamapsychiatry.86.

PMID:
23344076
8.

Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder.

Pearlman DM, Najjar S.

Schizophr Res. 2014 Aug;157(1-3):249-58. doi: 10.1016/j.schres.2014.05.001. Epub 2014 Jun 2. Review.

9.

Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis.

Pollak TA, McCormack R, Peakman M, Nicholson TR, David AS.

Psychol Med. 2014 Sep;44(12):2475-87. doi: 10.1017/S003329171300295X. Epub 2013 Dec 13. Review. Erratum in: Psychol Med. 2014 Sep;44(12):2488.

PMID:
24330811
10.

Cell- and Single Molecule-Based Methods to Detect Anti-N-Methyl-D-Aspartate Receptor Autoantibodies in Patients With First-Episode Psychosis From the OPTiMiSE Project.

Jézéquel J, Rogemond V, Pollak T, Lepleux M, Jacobson L, Gréa H, Iyegbe C, Kahn R, McGuire P, Vincent A, Honnorat J, Leboyer M, Groc L.

Biol Psychiatry. 2017 Nov 15;82(10):766-772. doi: 10.1016/j.biopsych.2017.06.015. Epub 2017 Jul 6.

PMID:
28780967
11.

Acute psychosis due to non-paraneoplastic anti-NMDA-receptor encephalitis in a teenage girl: Case report.

Kramina S, Kevere L, Bezborodovs N, Purvina S, Rozentals G, Strautmanis J, Viksna Z.

Psych J. 2015 Dec;4(4):226-30. doi: 10.1002/pchj.121.

PMID:
26663628
12.

High-throughput flow cytometry cell-based assay to detect antibodies to N-methyl-D-aspartate receptor or dopamine-2 receptor in human serum.

Amatoury M, Merheb V, Langer J, Wang XM, Dale RC, Brilot F.

J Vis Exp. 2013 Nov 23;(81):e50935. doi: 10.3791/50935.

13.

N-methyl-D-aspartate receptor antibody production from germinal center reactions: Therapeutic implications.

Makuch M, Wilson R, Al-Diwani A, Varley J, Kienzler AK, Taylor J, Berretta A, Fowler D, Lennox B, Leite MI, Waters P, Irani SR.

Ann Neurol. 2018 Mar;83(3):553-561. doi: 10.1002/ana.25173.

14.

N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis.

Prüss H, Finke C, Höltje M, Hofmann J, Klingbeil C, Probst C, Borowski K, Ahnert-Hilger G, Harms L, Schwab JM, Ploner CJ, Komorowski L, Stoecker W, Dalmau J, Wandinger KP.

Ann Neurol. 2012 Dec;72(6):902-11. doi: 10.1002/ana.23689.

15.

Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor.

Mohammad SS, Sinclair K, Pillai S, Merheb V, Aumann TD, Gill D, Dale RC, Brilot F.

Mov Disord. 2014 Jan;29(1):117-22. doi: 10.1002/mds.25623. Epub 2013 Oct 1.

PMID:
24115338
16.

Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis.

Deakin J, Lennox BR, Zandi MS.

Biol Psychiatry. 2014 Feb 15;75(4):284-91. doi: 10.1016/j.biopsych.2013.07.018. Epub 2013 Aug 26. Review.

PMID:
23988024
17.

Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care.

Schou M, Sæther SG, Borowski K, Teegen B, Kondziella D, Stoecker W, Vaaler A, Reitan SK.

Psychol Med. 2016 Dec;46(16):3303-3313. Epub 2016 Sep 9.

PMID:
27609625
18.

Molecular Pathogenicity of Anti-NMDA Receptor Autoantibody From Patients With First-Episode Psychosis.

Jézéquel J, Lepleux M, Kahn RS, Honnorat J, Leboyer M, Groc L.

Am J Psychiatry. 2018 Apr 1;175(4):382-383. doi: 10.1176/appi.ajp.2017.17091053. No abstract available.

PMID:
29606071
19.

Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.

Mikasova L, De Rossi P, Bouchet D, Georges F, Rogemond V, Didelot A, Meissirel C, Honnorat J, Groc L.

Brain. 2012 May;135(Pt 5):1606-21. doi: 10.1093/brain/aws092.

PMID:
22544902
20.

Dopamine-2 receptor extracellular N-terminus regulates receptor surface availability and is the target of human pathogenic antibodies from children with movement and psychiatric disorders.

Sinmaz N, Tea F, Pilli D, Zou A, Amatoury M, Nguyen T, Merheb V, Ramanathan S, Cooper ST, Dale RC, Brilot F.

Acta Neuropathol Commun. 2016 Dec 1;4(1):126.

Supplemental Content

Support Center